Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Int J Drug Policy. 2018 Mar 31;55:207–214. doi: 10.1016/j.drugpo.2018.03.014

Table 2.

Descriptive statistics for all substance use and sexual behaviours in the last 30 days (n = 500).

n (%) reporting any use M (SD) days of use Min, Max days of use
Sexualised drugs
 Cocaine 59 (11.8) 2.08 (1.92) 1, 10
 Ecstasy 35 (7.0) 1.66 (0.87) 1, 4
 Methamphetamine 15 (3.0) 4.40 (4.48) 1, 13
 Ketamine 15 (3.0) 2.53 (4.07) 1, 17
 GHB 11 (2.2) 3.00 (3.32) 1, 9
Non-sexualised drugs
 Alcohol 352 (70.4) 5.21 (4.73) 1, 30
 Alcohol to intoxication 422 (84.4) 4.51 (3.98) 1, 30
 Marijuana 267 (53.4) 14.78 (11.86) 1, 30
 Poppers 81 (16.2) 3.17 (3.25) 1, 17
 Pain killers 20 (4.0) 1.40 (0.82) 1, 4
 Hallucinogens 17 (3.4) 1.71 (1.10) 1, 4
 Stimulants 11 (2.2) 3.27 (3.50) 1, 13
 Anxiolytics 10 (2.0) 2.00 (1.49) 1, 5
 Cough Medicine 3 (0.6) 10.33 (16.17) 1, 29
 Crack 2 (0.4) 4.50 (4.95) 1, 8
 Opiates 2 (0.4) 4.50 (4.95) 1, 8
 Inhalants 1 (0.2) - -
 Viagra 1 (0.2) - -
 Cialis 0 (0.0) - -
 Levitra 0 (0.0) - -
 Sleeping pills 0 (0.0) - -
 Rohypnol 0 (0.0) - -

n (%) reporting any engagement in behaviour M (SD) sex acts Min, Max sex acts

Sexual behaviour
 Condomless oral receptive sex 371 (74.2) 4.86 (4.93) 1, 32
 Condomless anal insertive sex 149 (29.8) 3.81 (4.15) 1, 27
 Condomless anal receptive sex 147 (29.4) 3.94 (4.09) 1, 24
 Multiple partners 250 (50.0) 4.20 (3.18) 2, 23
 No sex while high 275 (55.0) - -
 Sex while high, any drug 225 (45.0) 1.45 (2.79) 1, 27
  Sex while high, sexualised drugs 48 (9.6) 2.29 (2.24) 1, 14
  Sex while high, non-sexualised drugs 177 (35.4) 1.23 (2.48) 1, 26